Pro-inflammatory Cytokine Signaling Pathways

Pro-inflammatory cytokine signaling pathways comprise a network of molecular cascades triggered by cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6), which are secreted by immune cells to mediate inflammation, immune cell recruitment, and tissue responses. These pathways rely on specific cytokine receptors and activate downstream effectors like the JAK/STAT and NF-κB signaling modules, ultimately leading to the transcription of genes involved in inflammation, immunity, cell survival, and apoptosis. Dysregulation of these pathways underlies a broad range of diseases, including autoimmunity, cancer, and chronic inflammatory disorders. Therapeutic strategies often center on blocking key cytokines or their receptors to attenuate pathological inflammation without compromising host defense against infection.

Other names

Pro-inflammatory cytokine pathwaysCytokine inflammatory signalingInflammatory cytokine signaling

Cytokine blockade (neutralizing antibody or receptor antagonist); Inhibition of downstream signal transduction (e.g., JAK/STAT inhibition, NF-κB inhibition); Modulation of cytokine production. (Mechanisms depend on the targeted pathway component; not on the broad pathway itself)